Whether the problem be zoonoses, diseases that may be transmitted from animals to man, or animal diseases that become epidemics, preventive or therapeutic vaccines are a vital alternative. Therapeutic vaccines, developed by molecular biology, are a particularly novel way of treating diseases, and are based on using interfering RNA molecules. Towards the end of 2005, CIRAD developed and patented interfering RNAs that act against the morbilliviruses that cause measles, rinderpest and peste des petits ruminants. Since then, research work has continued with a view to targeting the effect of these biological antivirals in animals.
As Emmanuel Albina* explains, "Unlike chemical molecules, interfering RNA fragments that are only active on the target virus or family of viruses block the virus development process within infected cells." He adds "this strategy completely changes all the concepts of disease control. The choice is no longer limited to eradicating the infected animal population or mass preventive vaccination. A third tool, therapeutic vaccines, could be used on infected animals."
This new biological approach to animal diseases primarily applies to those affecting ruminants (rinderpest, peste des petits ruminants, foot and mouth, etc) and swine - pigs, wild boars - (African swine fever).
Man could also benefit from these new techniques. Measles, a human disease that affects young people in developing countries, belongs to the same virus family as peste des petits ruminants and rinderpest. Pharmaceutical research has also jumped on the bandwagon and is looking to use the same techniques to treat cancer.
* immunology and microbiology researcher with CIRAD
Helen Burford | alfa
Plasma-zapping process could yield trans fat-free soybean oil product
02.12.2016 | Purdue University
New findings about the deformed wing virus, a major factor in honey bee colony mortality
11.11.2016 | Veterinärmedizinische Universität Wien
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Materials Sciences
06.12.2016 | Medical Engineering
06.12.2016 | Power and Electrical Engineering